Abstract In accordance with the present invention, a composition is provided that is effective in dissolving blood clots and reestablishing and maintaining blood flow through thrombosed coronary or other blood vessels. The fibrinolytic composition of the present invention comprises an enzyme, such as streptokinase, urokinase, tissue plasminogen activator or other fibrinolytic enzyme, and a surface-active copolymer. The surface-active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula: HO(C2H4O)b(C3H6O)a(C2H4O)bH wherein a is an integer such that the hydrophobe represented by (C3H6O) has a molecular weight of approximately 950 to 4000, preferably approximately 1750 to 3500, and b is an integer such that the hydrophile portion represented by (C2H4O) constitutes approximately 50% to 90% by weight of the compound.
A method of improving blood flow and oxygenation of a tumor in a human or animal, comprising the step of injecting into the human or animal a solution comprising an effective amount of a surface-active copolymer of the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (Chd 3H 6 O) has a molecular weight of approximately 950 to 4000, and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes from approximately 50% to 90% by weight of the compound.
Claim 2
Independent Claim
102 words
A method of improving blood flow and oxygenation of a tumor in a human or animal, comprising the step of injecting into the human or animal a solution comprising an effective amount of a surface-active copolymer of the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (Chd 3H 6 O) has a molecular weight of approximately 950 to 4000, and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes from approximately 50% to 90% by weight of the compound.
Claim 3
Dependent Claim
19 words
The method of claim 1, comprising the additional step of injecting the human or animal with a chemotherapeutic agent.
Claim 4
Dependent Claim
23 words
The method of claim 1, comprising the additional step of injecting the human or animal with a diagnostic reagent for detecting a tumor.
Claim 5
Dependent Claim
18 words
The method of claim 3, wherein the diagnostic reagent is a radioactively-labelled monoclonal antibody, specific for the tumor.
Claim 6
Dependent Claim
24 words
The method of claim 1, wherein the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 1750 to 4000.